Sign In
Buy SDZNY
$79.34
-0.468 (-0.586%)
At Close: Jun 03, 2026
Sandoz Group (OTCMKTS:SDZNY) versus Context Therapeutics (NASDAQ:CNTX) Head-To-Head Contrast
02:26am, Monday, 19'th Jan 2026
Sandoz Group (OTCMKTS:SDZNY - Get Free Report) and Context Therapeutics (NASDAQ: CNTX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two busines
Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:46pm, Tuesday, 13'th Jan 2026
Sandoz Group AG (SDZNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Financial Comparison: Daiichi Sankyo (OTCMKTS:DSNKY) vs. Sandoz Group (OTCMKTS:SDZNY)
02:00am, Wednesday, 07'th Jan 2026
Sandoz Group (OTCMKTS:SDZNY - Get Free Report) and Daiichi Sankyo (OTCMKTS:DSNKY - Get Free Report) are both large-cap medical companies, but which is the better business? We will contrast the two com
Sandoz Group (OTCMKTS:SDZNY) Trading Up 3.3% – What’s Next?
02:55am, Sunday, 28'th Dec 2025
Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY - Get Free Report) rose 3.3% during trading on Friday. The company traded as high as $76.84 and last traded at $76.84. Approximately 2,413 shares traded ha
SDZNY vs. STVN: Which Stock Is the Better Value Option?
12:41pm, Friday, 19'th Dec 2025
Investors interested in Medical - Drugs stocks are likely familiar with Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two stocks presents investors with the bett
3 Generic Drug Stocks to Watch Amid Changing U.S. Landscape
09:26am, Monday, 08'th Dec 2025
Generic drugmakers face U.S. pricing pressure, but TEVA, SDZNY and RDY gain momentum through complex generics and biosimilars.
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
01:20am, Monday, 08'th Dec 2025
All closing requirements satisfied following announcement of a non-binding term-sheet agreement in July and signing of contract in November Agreement includes approximately US$ 350 m in cash for Just
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Buy: Here's Why
01:01pm, Wednesday, 03'rd Dec 2025
Sandoz Group AG Sponsored ADR (SDZNY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 03'rd Dec 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Stevanato Group (STVN). But which of these two companies is the best o
Diamond Hill International Strategy Q3 2025 Portfolio Activity
09:05am, Monday, 17'th Nov 2025
We initiated seven new positions across themes including Japanese industrials, measured gold exposure and businesses with strong links to emerging markets. We initiated small positions in two companie
EirGenix ha firmado el acuerdo de licencia comercial para su segundo biosimilar de HER2, EG1206A
08:06pm, Wednesday, 12'th Nov 2025
/PRNewswire/ -- EirGenix Inc. (TWSE: 6589) anunció el 12 de noviembre la firma de un segundo acuerdo global de licencia exclusiva con Sandoz AG
EirGenix a signé un accord de licence commerciale pour son deuxième actif biosimilaire HER2, l'EG1206A
08:05pm, Wednesday, 12'th Nov 2025
/PRNewswire/ -- EirGenix Inc.(TWSE: 6589) annoncé le 12 novembre la conclusion d'un deuxième accord mondial de licence exclusive avec le leader international
Sandoz CEO expects Ozempic biosimilars to enter Canadian market in Q1, Q2
10:12am, Wednesday, 12'th Nov 2025
Generic drug giant Sandoz expects unbranded versions of Novo Nordisk's popular diabetes drug Ozempic to launch in Canada by the second quarter next year after a key patent expires, its CEO said on Wed
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
03:59am, Wednesday, 12'th Nov 2025
/PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar
EirGenix Signed The Commercial Licensinse Agreement for It's Second HER2 Biosimilar Asset EG1206A
03:15am, Wednesday, 12'th Nov 2025
TAIPEI , Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (
